Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares

Canadian Journal of Veterinary Research

Volumn 64, Issue 3, 2000, Pages 171-177

  Haines, Gregory R ^a   Brown, Murray P ^a   Gronwall, Ronald R ^a   Merritt, Kelly A ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; HORSE; INFECTION SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ABSORPTION; ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; FEMALE; FLUOROQUINOLONES; HORSES; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; QUINOLONES;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS; ESCHERICHIA COLI; KLEBSIELLA; PASTEURELLA; SALMONELLA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0033889652     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Dudley MN. Pharmacodynamics and pharmacokinetics of antibiotics with special references to the fluoroquinolones. Am J Med 1991;(Suppl):45-50.
2. Orsini JA, Perkons S. The fluoroquinolones: clinical applications in veterinary medicine. Compend Contin Educ Pract Vet 1992; 14:1491-1496.
3. Giguère S, Sweeney RW, Bélanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res 1996;57: 1025-1030.
4. Prescott JF, Baggot JD. Fluoroquinolones. In: Prescott JF, Baggot JD, eds. Antimicrobial Therapy in Veterinary Medicine. Ames: Iowa State University Press, 1993:252-262.
5. Moore RM, Schneider RK, Kowalski J, Bramlage LR, Mecklenburg LM, Kohn CW. Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989. Equine Vet J 1992;24:450-456.
6. Sweeney CR, Holcombe SJ, Barningham SC, Beech J. Aerobic and anaerobic bacterial isolates from horses with pneumonia or pleuropneumonia and antimicrobial susceptibility pattern of the aerobes. J Am Vet Med Assoc 1991;198:839-842.
7. Hawkins JF, Bowman KF, Roberts MC, Cowen P. Peritonitis in horses: 67 cases (1985-1990). J Am Vet Med Assoc 1993;203: 284-288.
8. Asbury AC, Lyle SK. Infectious causes of infertility. In: McKinnon AO, Voss JL, eds. Equine Reproduction. Philadelphia: Lea & Febiger, 1993:381-391.
9. Johnston JK, Divers TJ, Reef VB, Acland H. Cholelithiasis in horses: ten cases (1982-1986). J Am Vet Med Assoc 1989;194: 405-409.
10. Bostian A, Vivrette SL, Bermingham E, Papich MG. Quinolone-induced arthropathy in neonatal foals. Proc Annu Meet Coll Vet Intern Med 1998:723.
11. Burkhardt JE, Hill MA, Turek JJ, Carlton WW. Ultrastructural changes in articular cartilage of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 1992;29:230-238.
12. Burkhardt JE, Hill MA, Carlton WW, Kesterson JW. Histologic and histochemical changes in articular cartilage of immature beagle dogs dosed with difloxacin. Toxicol Pathol 1990;27: 162-170.
13. Burkhardt JE, Hill MA, Carlton WW. Morphologic and biochemical changes in articular cartilage of immature beagle dogs dosed with difloxacin. Toxicol Pathol 1992;20:246-252.
14. Gough AW, Olajide BK, Sigler RE, Baregi V. Quinolone arthropathy - acute toxicity to immature articular cartilage. Toxicol Pathol 1992;20:436-449.
15. Stahlman R, Forster C, Shakibaei M, Vormann J, Gunther T, Merker HJ. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother 1995;39:2013-2018.
16. Takada S, Kato M, Takayama S. Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles. J Toxicol Environ Health 1994;42:73-88.
17. Norrby SR. Side effects of quinolones: comparisons between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 1991;10:378-383.
18. Bertone AL, Tremaine WH, Macoris DG, Simmons EJ, Ewert KM, Weisbrode SE. Effect of the chronic systemic administration of an injectable enrofloxacin solution on physical, musculoskeletal, and histologic parameters in adult horses. Proc 44th Symp Am Assoc Equine Pract 1998:252-253.
19. Bennet JV, Brodie JL, Benner EJ, Kirby WM. Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiol 1966;14:170-177.
20. Caceci MS, Cacheris WP. Fitting curves to data. Byte 1984;9: 340-362.
21. Gibalbi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982.
22. Curry SH. Drug Disposition and Pharmacokinetics. Boston: Blackwell Scientific Publications, 1980.
23. Langston VC, Sedrish S, Boothe DM. Disposition of single-dose oral enrofloxacin in the horse. J Vet Pharmacol Therap 1997; 19:316-319.
24. Pyorala S, Panu S, Kaartinen L. Single-dose pharmacokinetics of enrofloxacin in horses. Proc Symp Eur Assoc Vet Pharmacol Toxicol 1994:45-46.
25. Giguère S, Bélanger M. Concentration of enrofloxacin in equine tissues after long term oral administration. J Vet Pharmacol Therap 1997;20:402-404.
26. Kaartinen L, Panu S, Pyorala S. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Vet J 1997;29:378-381.
27. Zehl U. Beitrag zur Pharmakokinetik des neuen Gyrasehemmers Baytril (enrofloxacin) beim Pferd (thesis). Durch die Tierärztliche Hochschule Hannover, 1989:87.
28. Ensink JM, van Klingeren B, Houwers DJ, Klein WR, Vulto AG. In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. Equine Vet J 1993;25: 309-313.
29. Prescott JF, Yielding KM. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin, and norfloxacin. Can J Vet Res 1990;54:195-197.
30. Boothe DM. Enrofloxacin revisited. Vet Med 1994;89:744-753.
31. Sullivan MC, Cooper BW, Nightingale CH, Quintiliani R, Lawlor MT. Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother 1993;37:234-239.
32. Drusano GL, Johnson DE, Rosen M, Standiford HC. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother 1993;37:483-490.
33. Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993;37: 1073-1081.
34. Meinen JB, McClure JT, Rosin E. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. Am J Vet Res 1995;56:1219-1224.